Vektor Medical is revolutionizing arrhythmia care with vMap, an FDA-cleared AI-based arrhythmia mapping solution. Their technology accurately maps atrial fibrillation and six other arrhythmias, optimized for use in the current procedural workflow. vMap provides rich 4-chamber insights from non-invasive ECG mapping, addressing a global health crisis by advancing care for arrhythmia patients. The company's focus is on unlocking insights contained in standard ECGs to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. vMap is FDA-indicated for 7 arrhythmias and 2 pacing types, aiming to enhance the treatment of cardiac arrhythmias and improve patient outcomes.